We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04377555
Brief Title: Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab.

First Submitted : May 1, 2020
First Submitted that Met QC Criteria : May 5, 2020
First Posted : May 6, 2020

Last Update Submitted that Met QC Criteria : September 12, 2022
Last Update Posted : September 13, 2022